Zoetis (ZTS) |
United States |
$78.843B |
32.06 |
Chugai Pharmaceutical (CHGCY) |
Japan |
$52.640B |
23.53 |
Takeda Pharmaceutical (TAK) |
Japan |
$41.776B |
8.46 |
Merck (MKGAF) |
Germany |
$23.037B |
22.34 |
Astellas Pharma (ALPMY) |
Japan |
$17.355B |
27.40 |
Sandoz Group AG (SDZNY) |
Switzerland |
$15.124B |
0.00 |
Neurocrine Biosciences (NBIX) |
United States |
$14.145B |
38.72 |
Shionogi (SGIOY) |
Japan |
$13.285B |
11.55 |
United Therapeutics (UTHR) |
United States |
$12.206B |
13.01 |
Catalent (CTLT) |
United States |
$9.947B |
0.00 |
Cerevel Therapeutics Holdings (CERE) |
United States |
$7.610B |
0.00 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$6.743B |
7.41 |
Revolution Medicines (RVMD) |
United States |
$6.543B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$5.645B |
23.81 |
Ionis Pharmaceuticals (IONS) |
United States |
$5.455B |
0.00 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$5.396B |
0.00 |
Madrigal Pharmaceuticals (MDGL) |
United States |
$5.168B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$3.904B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$3.107B |
0.00 |
Summit Therapeutics (SMMT) |
United States |
$3.082B |
0.00 |
Corcept Therapeutics (CORT) |
United States |
$2.998B |
27.17 |
PTC Therapeutics (PTCT) |
United States |
$2.980B |
0.00 |
Dyne Therapeutics (DYN) |
United States |
$2.851B |
0.00 |
Indivior (INDV) |
United States |
$2.351B |
11.14 |
Recursion Pharmaceuticals (RXRX) |
United States |
$2.232B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$2.065B |
11.74 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$1.952B |
19.00 |
Fusion Pharmaceuticals (FUSN) |
Canada |
$1.828B |
0.00 |
Evotec AG (EVO) |
Germany |
$1.804B |
0.00 |
Ardelyx (ARDX) |
United States |
$1.796B |
0.00 |
NewAmsterdam Pharma (NAMS) |
Netherlands |
$1.753B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$1.598B |
24.02 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$1.538B |
0.00 |
Soleno Therapeutics (SLNO) |
United States |
$1.479B |
0.00 |
Xencor (XNCR) |
United States |
$1.466B |
0.00 |
Pacira BioSciences (PCRX) |
United States |
$1.438B |
13.67 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$1.325B |
0.00 |
4D Molecular Therapeutics (FDMT) |
United States |
$1.300B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$1.129B |
6.75 |
Enliven Therapeutics (ELVN) |
United States |
$1.077B |
0.00 |
Cassava Sciences (SAVA) |
United States |
$1.068B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.061B |
16.54 |
Cronos Group (CRON) |
Canada |
$1.058B |
0.00 |
Relay Therapeutics (RLAY) |
United States |
$1.004B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$0.948B |
15.51 |
Ocular Therapeutix (OCUL) |
United States |
$0.945B |
0.00 |
Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$0.864B |
0.00 |
ARS Pharmaceuticals (SPRY) |
United States |
$0.856B |
0.00 |
ProKidney (PROK) |
United States |
$0.849B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$0.797B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$0.725B |
0.00 |
Silence Therapeutics (SLN) |
United Kingdom |
$0.716B |
0.00 |
Lyell Immunopharma (LYEL) |
United States |
$0.665B |
0.00 |
Calliditas Therapeutics AB (CALT) |
Sweden |
$0.640B |
0.00 |
Savara (SVRA) |
United States |
$0.594B |
0.00 |
Harrow (HROW) |
United States |
$0.583B |
0.00 |
Exscientia (EXAI) |
United Kingdom |
$0.568B |
0.00 |
Altimmune (ALT) |
United States |
$0.546B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.538B |
6.87 |
Heron Therapeutics (HRTX) |
United States |
$0.518B |
0.00 |
OmniAb (OABI) |
United States |
$0.506B |
0.00 |
Larimar Therapeutics (LRMR) |
United States |
$0.503B |
0.00 |
Lexeo Therapeutics (LXEO) |
United States |
$0.494B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.490B |
0.00 |
Bioventus (BVS) |
United States |
$0.488B |
18.67 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.483B |
0.00 |
Korro Bio (KRRO) |
United States |
$0.471B |
0.00 |
Verve Therapeutics (VERV) |
United States |
$0.465B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.457B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$0.444B |
0.00 |
Verrica Pharmaceuticals (VRCA) |
United States |
$0.372B |
0.00 |
Organogenesis (ORGO) |
United States |
$0.367B |
69.25 |
Tourmaline Bio (TRML) |
United States |
$0.360B |
0.00 |
Fractyl Health (GUTS) |
United States |
$0.349B |
0.00 |
Nanobiotix S.A (NBTX) |
France |
$0.335B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$0.312B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.297B |
18.89 |
Xeris Biopharma Holdings (XERS) |
United States |
$0.297B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.290B |
0.00 |
Black Diamond Therapeutics (BDTX) |
United States |
$0.280B |
0.00 |
ESSA Pharma (EPIX) |
Canada |
$0.275B |
0.00 |
Metagenomi (MGX) |
United States |
$0.266B |
0.00 |
Foghorn Therapeutics (FHTX) |
United States |
$0.265B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$0.264B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.237B |
0.00 |
Pyxis Oncology (PYXS) |
United States |
$0.236B |
0.00 |
Aldeyra Therapeutics (ALDX) |
United States |
$0.234B |
0.00 |
Eliem Therapeutics (ELYM) |
United States |
$0.228B |
0.00 |
Prelude Therapeutics (PRLD) |
United States |
$0.225B |
0.00 |
Conduit Pharmaceuticals (CDT) |
United States |
$0.221B |
0.00 |
Avita Medical (RCEL) |
United States |
$0.210B |
0.00 |
CytoDyn (CYDY) |
United States |
$0.206B |
0.00 |
Galectin Therapeutics (GALT) |
United States |
$0.201B |
0.00 |
Profound Medical (PROF) |
Canada |
$0.199B |
0.00 |
Adherex Technologies (FENC) |
United States |
$0.195B |
237.33 |
Zevra Therapeutics (ZVRA) |
United States |
$0.193B |
0.00 |
Century Therapeutics (IPSC) |
United States |
$0.193B |
0.00 |
Acrivon Therapeutics (ACRV) |
United States |
$0.186B |
0.00 |
Achieve Life Sciences (ACHV) |
Canada |
$0.177B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.176B |
0.00 |
Incannex Healthcare (IXHL) |
Australia |
$0.170B |
0.00 |
Telomir Pharmaceuticals (TELO) |
United States |
$0.169B |
0.00 |
MediWound (MDWD) |
Israel |
$0.163B |
0.00 |
Elite Pharmaceuticals (ELTP) |
United States |
$0.161B |
15.05 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.160B |
0.00 |
Context Therapeutics (CNTX) |
United States |
$0.152B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.152B |
0.00 |
Cardiol Therapeutics (CRDL) |
Canada |
$0.152B |
0.00 |
Citius Pharmaceuticals (CTXR) |
United States |
$0.132B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.132B |
0.00 |
OptiNose (OPTN) |
United States |
$0.131B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.124B |
0.00 |
Amylyx Pharmaceuticals (AMLX) |
United States |
$0.122B |
8.18 |
FibroGen (FGEN) |
United States |
$0.118B |
0.00 |
PMV Pharmaceuticals (PMVP) |
United States |
$0.110B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.101B |
1.42 |
ProPhase Labs (PRPH) |
United States |
$0.099B |
0.00 |
Vivani Medical (VANI) |
United States |
$0.098B |
0.00 |
Relmada Therapeutics (RLMD) |
United States |
$0.098B |
0.00 |
Assertio Holdings (ASRT) |
United States |
$0.097B |
4.43 |
AlloVir (ALVR) |
United States |
$0.092B |
0.00 |
ARYA Sciences Acquisition Corp IV (ARYD) |
United States |
$0.086B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.084B |
0.00 |
Tempest Therapeutics (TPST) |
United States |
$0.075B |
0.00 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.073B |
0.00 |
Journey Medical (DERM) |
United States |
$0.067B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.064B |
0.00 |
Mural Oncology (MURA) |
Ireland |
$0.064B |
0.00 |
Reneo Pharmaceuticals (RPHM) |
United States |
$0.063B |
0.00 |
Protara Therapeutics (TARA) |
United States |
$0.060B |
0.00 |
Carisma Therapeutics (CARM) |
United States |
$0.059B |
0.00 |
Inotiv (NOTV) |
United States |
$0.055B |
0.00 |
Nutriband (NTRB) |
United States |
$0.054B |
0.00 |
BioLineRx (BLRX) |
Israel |
$0.050B |
0.00 |
Gain Therapeutics (GANX) |
United States |
$0.045B |
0.00 |
CASI Pharmaceuticals (CASI) |
China |
$0.041B |
0.00 |
NRx Pharmaceuticals (NRXP) |
United States |
$0.041B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.041B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.041B |
0.00 |
DURECT (DRRX) |
United States |
$0.040B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.039B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.039B |
0.00 |
VYNE Therapeutics (VYNE) |
United States |
$0.039B |
0.00 |
Unicycive Therapeutics (UNCY) |
United States |
$0.039B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.036B |
0.00 |
Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.036B |
0.00 |
Lipocine (LPCN) |
United States |
$0.035B |
0.00 |
Viracta Therapeutics (VIRX) |
United States |
$0.031B |
0.00 |
Surrozen (SRZN) |
United States |
$0.031B |
0.00 |
JanOne (JAN) |
United States |
$0.030B |
0.00 |
Enlivex Therapeutics (ENLV) |
Israel |
$0.028B |
0.00 |
Oncternal Therapeutics (ONCT) |
United States |
$0.025B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.024B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.023B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.023B |
0.00 |
PolyPid (PYPD) |
Israel |
$0.023B |
0.00 |
Lyra Therapeutics (LYRA) |
United States |
$0.022B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.021B |
0.80 |
Indaptus Therapeutics (INDP) |
United States |
$0.020B |
0.00 |
Aptorum Group (APM) |
United Kingdom |
$0.020B |
0.00 |
BioVie (BIVI) |
United States |
$0.019B |
0.00 |
Talphera (TLPH) |
United States |
$0.018B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.018B |
0.00 |
Nuvilex (PMCB) |
United States |
$0.018B |
0.00 |
Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.018B |
0.00 |
Minerva Neurosciences (NERV) |
United States |
$0.017B |
0.00 |
Alaunos Therapeutics (TCRT) |
United States |
$0.017B |
0.00 |
Traws Pharma (TRAW) |
United States |
$0.017B |
0.00 |
XTL Biopharmaceuticals (XTLB) |
Israel |
$0.015B |
0.00 |
CERo Therapeutics Holdings (CERO) |
United States |
$0.015B |
0.00 |
Mannatech (MTEX) |
United States |
$0.015B |
0.00 |
Kiora Pharmaceuticals (KPRX) |
United States |
$0.015B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.014B |
0.00 |
Mangoceuticals (MGRX) |
United States |
$0.013B |
0.00 |
Dominari Holdings (DOMH) |
United States |
$0.013B |
0.00 |
Inhibikase Therapeutics (IKT) |
United States |
$0.012B |
0.00 |
Plus Therapeutics (PSTV) |
United States |
$0.012B |
0.00 |
Cosmos Health (COSM) |
Greece |
$0.012B |
0.00 |
Avalo Therapeutics (AVTX) |
United States |
$0.011B |
0.00 |
Biomerica (BMRA) |
United States |
$0.011B |
0.00 |
Universe Pharmaceuticals INC (UPC) |
China |
$0.009B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.009B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.009B |
0.00 |
TransCode Therapeutics (RNAZ) |
United States |
$0.008B |
0.00 |
SHINECO (SISI) |
China |
$0.008B |
0.00 |
Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.007B |
0.00 |
Vivos Therapeutics (VVOS) |
United States |
$0.007B |
0.00 |
Ainos (AIMD) |
United States |
$0.006B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.006B |
0.00 |
Heatwurx (PCSA) |
United States |
$0.005B |
0.00 |
XORTX Therapeutics (XRTX) |
Canada |
$0.005B |
0.00 |
MyMD Pharmaceuticals (MYMD) |
United States |
$0.005B |
0.00 |
Petros Pharmaceuticals (PTPI) |
United States |
$0.005B |
0.00 |
Phio Pharmaceuticals (PHIO) |
United States |
$0.003B |
0.00 |
60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.003B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.003B |
0.00 |
Quoin Pharmaceuticals (QNRX) |
United States |
$0.003B |
0.00 |
Altamira Therapeutics (CYTO) |
Bermuda |
$0.002B |
0.00 |
Salarius Pharmaceuticals (SLRX) |
United States |
$0.002B |
0.00 |
Avenue Therapeutics (ATXI) |
United States |
$0.002B |
0.00 |
Clearmind Medicine (CMND) |
Canada |
$0.002B |
0.00 |
InMed Pharmaceuticals (INM) |
Canada |
$0.002B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.002B |
0.00 |
Qualigen Therapeutics (QLGN) |
United States |
$0.002B |
0.00 |
PainReform (PRFX) |
Israel |
$0.002B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.001B |
0.00 |
SciSparc (SPRC) |
Israel |
$0.001B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.001B |
0.00 |
Aditxt (ADTX) |
United States |
$0.001B |
0.00 |
Qilian Holding Group (QLI) |
China |
$0.000B |
0.00 |
Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
NLS Pharmaceutics (NLSP) |
Switzerland |
$0.000B |
0.00 |
Procaps Group, S.A (PROC) |
Luxembourg |
$0.000B |
5.63 |
Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
Stevanato Group S.p.A (STVN) |
Italy |
$0.000B |
32.64 |